近期术前阿片类药物处方与显微乳房再造术后并发症增加相关
基于TriNetX全国数据库的回顾性队列分析,纳入2010-2025年接受显微乳房再造的成年女性,经1:1倾向评分匹配后比较近期阿片类药物暴露组与非暴露组。结果显示阿片暴露组30天伤口裂开、手术部位感染、脓毒症、尿路感染和肺栓塞风险均显著升高,且再入院、急诊就诊和1年内再手术率更高。
要点
- 近期术前阿片暴露增加显微乳房再造术后30天伤口裂开、SSI、脓毒症、UTI和PE风险
- 阿片暴露组再入院、急诊就诊及1年内再手术风险显著升高
- 术前应识别近期阿片使用并优化围手术期管理
核心结论
- 近期术前阿片类药物使用是显微乳房再造术后早期和晚期并发症的显著危险因素。
研究设计与样本
- 回顾性队列分析,使用TriNetX全国数据库,纳入2010-2025年接受显微乳房再造的成年女性,共23,471例,经1:1倾向评分匹配后阿片组与非阿片组各3,780例。
主要发现
- 阿片组30天伤口裂开风险RR 1.37(p=0.006),手术部位感染RR 1.35(p=0.008),脓毒症RR 1.59(p=0.040),尿路感染RR 2.04(p=0.040),肺栓塞RR 2.24(p=0.013)。
- 阿片组30天再入院RR 1.25(p=0.036),急诊就诊RR 1.57(p<0.001),1年内再手术RR 1.29(p<0.001)。
临床怎么用
- 术前评估应询问近期阿片类药物使用情况,并将其纳入显微乳房再造术后并发症风险分层。
- 对近期有阿片暴露的患者,围手术期可考虑加强伤口监测、感染预防及出院后随访。
局限性
- 本研究为回顾性数据库分析,可能存在未测量的混杂因素;阿片暴露的定义及剂量信息未在摘要中详述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opioids are frequently prescribed during breast cancer treatment, resulting in patients presenting with recent opioid exposure for microsurgical breast reconstruction (MBR). However, the effect of preoperative opioid use on postoperative outcomes following MBR remains poorly defined. We evaluated whether recent opioid exposure is associated with increased postoperative complications and healthcare utilization after MBR. METHODS: In this retrospective cohort analysis using the TriNetX national database, adult female patients who underwent MBR (2010-2025) were identified and 1:1 propensity score matching was performed. These patients were then divided into two groups: matched opioid use and matched non-opioid use groups. Primary outcomes were 30-day complications (wound dehiscence, surgical site infection [SSI], sepsis, urinary tract infection [UTI], and pulmonary embolism [PE]). Secondary outcomes were 30-day hospital readmission and emergency department (ED) visits, and reoperation within 1 year. The Pearson chi-squared test or Fisher's exact test and t-test were used to compare the cohorts, and multivariable regression analysis was conducted for each outcome to calculate risk ratios (RRs). Statistical significance was set at p<0.05. RESULTS: Among the 23,471 patients, 3780 in the opioid use group were matched to 3780 non-opioid use controls. The opioid use group had higher 30-day complication rates: wound dehiscence (RR 1.37, p=0.006), SSI (RR 1.35, p=0.008), sepsis (RR 1.59, p=0.040), UTI (RR 2.04, p=0.040), and PE (RR 2.24, p=0.013). Healthcare utilization was greater among the opioid users, with increased readmissions (RR 1.25, p=0.036), ED visits (RR 1.57, p<0.001), and reoperations (RR 1.29, p<0.001). CONCLUSION: Recent preoperative use of opioids is a significant risk factor for early and late complications following MBR.
引用
- Fuentes PM, Dao MQ, Lascar E, et al. Recent preoperative opioid prescription is associated with increased complications after microsurgical breast reconstruction. J Plast Reconstr Aesthet Surg. 2026. PMID: 41633092. doi:10.1016/j.bjps.2026.01.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。